Ackman's Pershing Square sells Valeant stake, takes $3 billion loss
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/1/2026
- Wall St on track for subdued September start as high yields, oil prices dent sentiment
- Oil up more than 2% as renewed US-Iran strikes stoke supply fears
- Two Saudi tankers struck in Strait of Hormuz Monday
- The Warsh pivot markets didn't expect
- Oil settles up by more than 2.5% as US and Iran resume military attacks
Valeant Pharma (VRX) Offering Said to Price at $11.10/Share, Low End of Range - Bloomberg
March 14, 2017 8:13 AM EDTValeant Pharma (NYSE: VRX) Offering Said to Price at $11.10/Share, Low End of Range - Bloomberg
... More
